Days Inventory is also known as Days Sales of Inventory (DSI). UroGen Pharma's Average Total Inventories for the
three
months ended in Dec. 2024 was $8.41 Mil. UroGen Pharma's Cost of Goods Sold for the
three
months ended in Dec. 2024 was $2.47 Mil.
Hence, UroGen Pharma's Days Inventory for the
three
months ended in Dec. 2024 was 310.59.
The historical rank and industry rank for UroGen Pharma's Days Inventory or its related term are showing as below:
LTS:0XOD'
s Days Inventory Range Over the Past 10 Years
Min: 63.97 Med: 229.42 Max: 1368.75
Current: 305.6
During the past 10 years, UroGen Pharma's highest Days Inventory was 1368.75. The lowest was 63.97. And the median was 229.42.
LTS:0XOD's Days Inventory is ranked worse than 70.65% of 644
companies
in the Biotechnology industry
Industry Median: 177.045
vs LTS:0XOD: 305.60
UroGen Pharma's Days Inventory
increased
from Dec. 2023 (213.06) to Dec. 2024 (310.59).
It might indicate that UroGen Pharma's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
UroGen Pharma's Inventory Turnover for the
three
months ended in Dec. 2024 was 0.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
UroGen Pharma's Inventory-to-Revenue for the
three
months ended in Dec. 2024 was 0.34.
UroGen Pharma Days Inventory Historical Data
The historical data trend for UroGen Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of UroGen Pharma's Days Inventory
For the Biotechnology subindustry, UroGen Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UroGen Pharma's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, UroGen Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where UroGen Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UroGen Pharma (LTS:0XOD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
UroGen Pharma's Inventory Turnover for the
three
months ended in Dec. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
UroGen Pharma's Inventory to Revenue for the
three
months ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
UroGen Pharma Days Inventory Related Terms
Thank you for viewing the detailed overview of UroGen Pharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0XOD has been successfully added to your 